164 related articles for article (PubMed ID: 18669516)
1. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus.
Hobbs JK; Miller K; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2008 Nov; 62(5):1003-8. PubMed ID: 18669516
[TBL] [Abstract][Full Text] [Related]
2. XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.
Ooi N; Miller K; Hobbs J; Rhys-Williams W; Love W; Chopra I
J Antimicrob Chemother; 2009 Oct; 64(4):735-40. PubMed ID: 19689976
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
Begic D; von Eiff C; Tsuji BT
J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
[TBL] [Abstract][Full Text] [Related]
4. Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus.
O'Neill AJ; Miller K; Oliva B; Chopra I
J Antimicrob Chemother; 2004 Dec; 54(6):1127-9. PubMed ID: 15531595
[TBL] [Abstract][Full Text] [Related]
5. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.
Silverman JA; Perlmutter NG; Shapiro HM
Antimicrob Agents Chemother; 2003 Aug; 47(8):2538-44. PubMed ID: 12878516
[TBL] [Abstract][Full Text] [Related]
6. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].
Hernández Martí V; Romá Sánchez E; Salavert Lletí M; Bosó Ribelles V; Poveda Andrés JL
Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024
[TBL] [Abstract][Full Text] [Related]
7. Anti-staphylococcal activity and mode of action of clofazimine.
Oliva B; O'Neill AJ; Miller K; Stubbings W; Chopra I
J Antimicrob Chemother; 2004 Mar; 53(3):435-40. PubMed ID: 14762055
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Leonard SN; Rybak MJ
J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
[TBL] [Abstract][Full Text] [Related]
9. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
[TBL] [Abstract][Full Text] [Related]
10. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Camargo IL; Neoh HM; Cui L; Hiramatsu K
Antimicrob Agents Chemother; 2008 Dec; 52(12):4289-99. PubMed ID: 18824611
[TBL] [Abstract][Full Text] [Related]
11. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
Smith K; Perez A; Ramage G; Gemmell CG; Lang S
Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical experience with daptomycin.
Hawkey PM
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii7-14. PubMed ID: 18829726
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin inoculum effects and mutant prevention concentration with Staphylococcus aureus.
Quinn B; Hussain S; Malik M; Drlica K; Zhao X
J Antimicrob Chemother; 2007 Dec; 60(6):1380-3. PubMed ID: 17905797
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients.
Sader HS; Fritsche TR; Jones RN
Int J Infect Dis; 2009 Mar; 13(2):291-5. PubMed ID: 18938097
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization.
Muthaiyan A; Silverman JA; Jayaswal RK; Wilkinson BJ
Antimicrob Agents Chemother; 2008 Mar; 52(3):980-90. PubMed ID: 18086846
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
Dhawan B; Gadepalli R; Kapil A
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):196-8. PubMed ID: 19748433
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the antimicrobial activity of bis(Nalpha-caproyl-L-arginine)-1,3-propanediamine dihydrochloride and chlorhexidine dihydrochloride against Staphylococcus aureus and Escherichia coli.
Castillo JA; Clapés P; Infante MR; Comas J; Manresa A
J Antimicrob Chemother; 2006 Apr; 57(4):691-8. PubMed ID: 16467368
[TBL] [Abstract][Full Text] [Related]
19. The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models.
Smirnova MV; Vostrov SN; Strukova EV; Dovzhenko SA; Kobrin MB; Portnoy YA; Zinner SH; Firsov AA
J Antimicrob Chemother; 2009 Oct; 64(4):815-20. PubMed ID: 19671586
[TBL] [Abstract][Full Text] [Related]
20. Who's winning the war?
Gould IM
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii3-6. PubMed ID: 18829723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
